Abstract Endoprosthetic reconstruction after resection of a primary bone malignancy has become an established surgical modality that preserves the limb without compromising oncologic survival. Tumours arising from the proximal tibia and distal femur pose a unique set of challenges in the management of soft tissues and the restoration of limb length and joint kinetics. These issues are especially complex in the skeletally immature patient. The focus of this article is to review recent innovations in modern endoprosthetic design, with a focus on outcomes and treatment of surgical complications such as infection, aseptic loosening and extensor mechanism failure. We also review functional outcomes across various types of endoprosthetic designs.
Introduction
Limb-sparing surgery (LSS) has become a conventional means of surgical management for patients with a primary bone malignancy as a result of advances in imaging technology, chemotherapy regimens and modern endoprosthetic implant design. Whereas in the past ablative surgery was considered the standard of care, indications for LSS have expanded over time and 90-95 % of these tumours are now salvageable with a variety of reconstructive options without oncologic compromise [1] [2] [3] [4] [5] . Overall survival in bone sarcoma patients as a result of these advances ranges from 61 to 92 % [2, 3, [6] [7] [8] [9] and rates of local recurrence are reported as ranging from 0 to 16 % [3, 5, 8, 9] . Optimising function and preventing long-term complications after the appropriate oncologic treatment remains a challenge.
The knee is one of the most common locations for bone sarcoma [4, 10, 11] . Tumours arising from the proximal tibia and distal femur pose a unique set of challenges in the management of soft tissues and the restoration of limb length and joint kinetics. These issues become especially complex in the skeletally immature patient where predicting growth and leg length discrepancy can be imprecise, fraught with complications and accompanied by unrealistic patient and family expectations [4, 12 •• ] .
Over the years, innovation in implant design has moved from fixed to rotating hinge endoprosthetic replacements (EPR), custom to modular designs that may be cemented, press-fit or compressed, and a spectrum of invasive to non-invasive growing mechanisms. The goal of this review is to highlight the evolution of these implants, as well as the limitations, complications and functional outcomes that can be expected from this reconstructive option.
Why Choose Endoprosthetic Replacement?
There is a gamut of viable surgical options for extremity bone sarcoma, including amputation, rotationplasty, irradiation/reimplantation, allograft/allograft-prosthetic composites and EPR. Less than 10 % of patients require amputation in modern patient series, and endoprostheses have become the most conventional form of reconstruction [1] [2] [3] 9] . Oncologic outcome, quality of life, function and cost each play a role in selecting the best reconstructive option, as does surgeon and patient preference.
When amputation has been compared with LSS in observational studies, a significant number report better function, lower lifetime cost and similar oncologic outcomes in patients treated with LSS [1] [2] [3] [4] [5] 12 •• , [13] [14] [15] [16] . However, these functional outcome findings are mitigated by relatively small patient cohorts, a heterogeneous group of limb-salvage procedures and frequent selection bias as those undergoing amputation often have more extensive disease and potentially more biologically aggressive tumours. Additionally, very few studies directly compare amputation to EPR.
In a large, multicentre review of 227 cases of distal femoral osteosarcoma, Rougraff et al. [5] reported superior functional outcomes (MSTS, Knee Society score) in LSS patients as compared to amputation, despite a 41 % reoperation rate in the LSS group. Thirty-four of the 73 LSS patients were treated with an EPR. The Scandinavian Sarcoma Group reported on 118 patients with extremity bone sarcoma treated with LSS compared with amputation with a mean follow-up of 13 years. Ninety-four of these patients had tumours located in the femur or tibia and 57 % were managed with LSS. TESS scores, rates of employment and physical activity level were found to be equivalent in both groups, whereas quality of life, as measured by the SF-36, was found to be significantly in favour of LSS patients in the domains of physical function and bodily pain although the overall SF-36 was not significantly different between the two groups. Nearly all patients with very poor function (MSTS \50 %) were amputee patients [1] . The most recent comparison of amputation and EPR in bone sarcoma about the knee was a study by Malek et al. [17 •• ] , who demonstrated better reintegration to normal living index and Physiological Cost Index (PCI) scores (a validated measure of the oxygen cost of walking) amongst EPR patients at a median 56-month follow-up. They were, however, unable to detect a difference in perceived quality of life, TESS or SF-36 scores. Although a small study with retrospective design, this is one of the few comparison studies evaluating EPR alone as the limb-salvage procedure in the distal femoral and proximal tibial sarcoma with a number of functional outcome measures.
In cost-effectiveness studies, evidence points to amputation and rotationplasty being more expensive over a patient's lifetime as a result of external prosthetic devices, despite the increased number of surgical interventions in patients managed with an implant [18 •• , 19] . Grimer et al. [19] derived a formula to calculate the total cost of amputation compared to non-extendible EPRs, taking into account index procedure cost, years of follow-up and outpatient expenditures, as well as the risk and cost of ''servicing'' and revision procedures. Nearly eightfold in savings were projected with the use of an EPR over 20 years. Gait analysis studies have also documented improved gait patterns and reduced oxygen consumption in patients treated with an EPR [17 •• , 20-22] . One multicentre, cross-sectional study of bone sarcoma located around the knee demonstrated better TUDS (time walking up and down stairs) and VMA walking tests in LSS patients under the age of 25 years, but no difference in TESS score, PCI or Baecke indices for sport, leisure and work function
Endoprosthetic reconstruction has been associated with a significant rate of complications requiring revision over time, although these figures have diminished since the introduction of modern implants [4, 5, 10, 11] . Some evidence points to rotationplasty being a more durable reconstruction, but this is also mitigated by complications such as fracture, vascular compromise, malrotation as well as issues around cosmesis and body image [24] [25] [26] .
Controversies and Advances in Implant Design
In early prosthetic designs, implants around the knee used a fixed hinge, fully constrained prosthesis. In our centre, the implant (based on a Stanmore knee replacement) was fitted with a central axis and small articulated tibial pin (Stanmore Implants, Elstree, UK), the latter of which was prone to wear [9] . Over time, this was replaced with a rotating hinge mechanism in order to decrease the rotational stress on the implant and polyethylene bushings [9, 27, 28] . The original implants were made of titanium alloy, but in the tibia in particular, this led to significant metallosis in the soft tissues. The implants were subsequently coated with a titanium nitride so as to increase resistance to wear and corrosion, which successfully reduced this occurrence. A hydroxyapatite collar was added at the junction of the prosthesis with the stem to promote bone ingrowth [9, 29 •• ]. Myers et al. reported a series of 194 patients with a proximal tibial sarcoma that demonstrated a reduction in rates of aseptic loosening from 46 to 3 % at 10 years with the adoption of a modern rotating hinge design [11] . There was also a risk reduction of over 50 % in reoperation for any reason at 15 years follow-up. Similarly, in distal femoral EPRs, our centre reported our 30-year experience across 335 patients and found a risk reduction of 52 % with the use of a rotating hinge implant with a hydroxyapatite (HA) collar [10] . Causes of failure in the rotating hinge implant were infection and stem fracture, whereas aseptic loosening was most commonly associated with failure and revision in the fixed hinge prosthesis. The major advances in endoprosthetic design over the past few decades are detailed in Fig. 1 .
Cement, Press-Fit or Compress?
Good to excellent results have been obtained in both cemented and uncemented implant designs; however, the rate of surgical complications and revisions remains high in both. A third generation cementing technique is typically employed, and reaming allows for a 1-2-mm cement mantle. The rotational forces on the prosthesis are mitigated by the use of the rotating hinge, an anti-rotation lug and an HA-coated collar. Our centre has reported implant survival of cemented stems in distal femoral prostheses of 83, 67 and 42 % at 5, 10 and 20 years, respectively, and in the proximal tibia, 88, 75 and 70 % at 5, 10 and 15 years, respectively [10, 11] . These figures are similar in other series [30, 31 • 
The use of HA collars has been developed for both cemented and uncemented stems (Fig. 2) , and has been shown to promote bony ingrowth and decrease the rates of aseptic loosening by stabilising the stem and cement mantle and preventing the tracking of osteolytic wear debris down the canal [ [34] reported the long-term results of 59 patients treated at the Mayo Clinic with extra-cortical bone bridging and ingrowth fixation of a porous coated stem. Porous coating of titanium fiber metal or cobalt-chromium beads at the implant shoulder was combined with allo-or autografting at the bone-implant interface at the time of implantation. The majority of stems were cemented, with the exception of seven. Overall, there was no difference in bony ingrowth radiographically between cemented and uncemented stems as measured in four zones (87 % ± 26 vs. 67 % ± 32, p = 0.29), and stem loosening occurred in only two stems in one arthrodesis patient. Finite element analyses support increased stem and cement mantle stability secondary to this technique [37] ; however, retrieval studies were not originally able to correlate radiographic bone ingrowth with osseous integration histologically [38] . In 2013, Coathup et al. [29 • • ] presented the long-term survival of cemented Stanmore distal femoral EPRs with an HA collar. The authors found evidence of mature lamellar bone within the HA-collar grooves on light microscopy as compared to fibrous tissue in a small comparative group of EPRs retrieved with no collar. Seventy per cent of stems were ingrown radiographically; however, there was no significant difference in the overall survival in collars showing ingrowth versus those that did not, and as such, the clinical significance is still unknown.
Uncemented stems were developed in the hopes of promoting biologic ingrowth, and increased stability and longevity of EPRs. A fully porous coated anchorage stem and splines are present in some designs to neutralise the rotational forces at the bone-implant interface, and underreaming by 0.5 mm helps to create a press-fit of the implant into cortical bone [39] . The Kotz Modular Femur and Tibia Resection System (KMFTR; Howmedica, Stryker, Osteonics, Rutherford, NJ) is a fixed-hinge implant, which initially had holes and a side plate for cross-fit screws; however, this was abandoned secondary to increased rates of stress shielding [40] . Similar to cemented prostheses, aseptic loosening, implant breakage and infection are common modes of long-term failure [39] . However, some series have reported decreased rates of aseptic loosening [28, [39] [40] [41] . Flint et al. [40] reported no cases of aseptic loosening in 44 consecutive patients treated with an uncemented proximal tibial EPR at a mean of 60 months (range 9-162). The functional scores analysed showed a mean TESS score of 75 and a mean MSTS of 25. A specific concern of uncemented stems revolves around the period of postoperative chemotherapy where little bony ingrowth occurs. Weight-bearing protocols vary between centres, and some elect to protect weight-bearing for 12 weeks during this period of adjuvant treatment, which may be disadvantageous for patients [40] . No consensus, however, exists regarding postoperative weight-bearing status, and a significant amount of variability between centres' postoperative protocols was observed.
Concern over the high rates of complications in both cemented and uncemented endoprostheses led to the development of an alternative biologically fixed implant, the Compress Ò Compliant Pre-Stress Implant (Biomet, Warsaw, IN), which attempts to achieve stem fixation by compressing stored energy through a short traction bow secured with transverse pins [43 [42] have also compared the Compress Ò with press-fit EPRs in a retrospective series of 91 patients. They reported no difference in 5-year prosthetic survival (85 vs. 88 %, p = 0.9) or the number of failures. Uncemented prostheses failed primarily because of aseptic loosening, as well as a stem fracture in one patient; the Compress Ò failed as a result of femoral fracture and distal bone resorption at the compression site. Stem diameter less than 13.5 mm was associated with decreased implant survival in the press-fit group. While short-and medium-term outcomes are encouraging, longer-term follow-up with larger patient cohorts are needed to assess the durability of this implant.
Modular Versus Custom EPR
Custom-designed implants are available for both distal femur and proximal tibial endoprostheses, and their use varies by institution. In our centre, the majority of patients with a primary bone tumour will receive a custom EPR. Radiographic protocol films are taken prior to commencing neoadjuvant treatment. The level of resection is determined based on the initial staging studies, and an implant is ordered. Repeat staging prior to surgery is required to ensure that there has been no change in tumour extent. It is most unusual for there to be a significant change in the extent of tumour within the bone, but nonetheless, care must be taken to carry out the appropriate level of resection in these scenarios.
Modular designs are also available and used in many centres for both metastatic disease and primary bony sarcoma. In 2010, Schwartz et al. [32 • ] reported a trend toward improved implant survival in 29 modular implants compared to 23 custom-designed proximal tibial prostheses. However, the custom implants dated from 1985 to 1989, while modular components were more modern designs. Similar findings were reported in their series of 186 distal femoral EPRs; however, the custom-made, onepiece casted implants also dated back before the 1990s [31 • ]. Other centres using both modular and custom systems have reported similar implant-related survival [45] [46] [47] [48] [49] , although to our knowledge no direct comparisons of modern implants have been carried out.
Growing Implants Scales and Sneath [50] were the first to describe expandable prostheses in the skeletally immature patient with bone sarcoma. This population is difficult to treat secondary to the imprecision of predicting limb length and the longevity required of these implants [51 •• , [52] [53] [54] . There have been tremendous changes in the design of these constructs since their inception (Fig. 3) , predominantly as a result of the considerable complication rates. Open lengthening procedures were the standard in early designs, but we have progressively moved toward minimally invasive techniques so as to prevent major soft tissue dissection and infection as a result of multiple procedures. Noninvasive expandable implants are a novel means of eliminating surgical intervention to achieve limb length [55] ; electromagnetic induction can be used in an outpatient setting for EPR lengthening.
Mixed results have been reported. Ruggieri et al. [56 
Surgical Complications: What to Expect
While endoprosthetic replacement has become an established method of limb salvage and innovation in Fig. 3 Expandable total femoral replacement. This picture shows a minimally invasive growing implant, now fully expanded and explanted as patient required conversion to an adult prosthesis biomedical engineering has significantly improved upon patient outcomes, a significant number of surgical complications can be expected. In particular, mid-and longterm complications such as infection, aseptic loosening, mechanical failure and secondary amputation significantly limit the success of EPR reconstruction about the knee [44] ( Table 1) . Lymphedema, extensor mechanism failure and chronic pain also contribute to poor outcomes in this patient population. Henderson and colleagues have classified segmental endoprosthetic failure using a multi-institutional review of five centres' outcomes following EPRs. They observed 534 failures in 2,174 (24.6 %) patients over 34 years. Forty-four per cent involved the distal femur, 14 % the proximal tibia and 2 % both. Types of failure were classified as mechanical (49 % A variety of implant-related solutions have been proposed to decrease infection rates in EPRs. Silver-coated prostheses have shown excellent promise and are now used in nearly all revision EPRs for sarcoma and revision arthroplasty patients in our centre. Silver is bactericidal against a range of bacteria. In vitro and animal studies have shown it to be efficacious against Staphylococcus epidermidis species and to reduce the risk of infection in silver-coated EPRs in a rabbit model [ . A heterogeneous series of 222 patients were treated with an iodine-coated implant and followed for a mean of 18.4 months (range 3-44); 32 patients had a megaprosthesis for tumour [81 •• ] . Two per cent developed an infection in those treated prophylactically with an iodine-coated implant; no implant removal was required. No adverse thyroid function was observed for the study duration. Long-term follow-up of these metallic-coated prostheses is clearly needed as well as careful documentation of adverse systemic events; however, they show early promise in modifying infection risk.
Aseptic Loosening
Aseptic loosening is one of the most common causes of late implant failure, along with infection, and has been the subject of much scrutiny and research (Fig. 4) . In a large series of 295 patients, a type 2 failure occurred in 4.5 % of primary EPRs and 6.1 % in revision cases; mean time to failure was 2.6 and 3.1 years, respectively [82 •• ] . The distal femur showed the highest rate of type 2 failures. Henderson et al. found aseptic loosening to be the second most common mode of failure across EPRs in both the upper and lower extremities in a large multicentre series of 2,174 patients. Fixed hinge prostheses showed an increased incidence of aseptic loosening compared to rotating hinge mechanisms (p = 0.0004) [63 •• ] , which is consistent with the results of other major series in the literature. As previously discussed, much innovation has occurred at the level of implant design so as to minimise this complication. In a retrospective series of proximal tibial EPRs, Schwartz et al. [32 • ] reported a 19 % revision rate, 60 % of which were secondary to aseptic loosening at a mean of 11.8 years. They also reported high rates of failure after converting a porous-coated ingrowth surface on the tibia to a smooth design, and this was quickly abandoned. Other innovations have included the addition of an HA collar to achieve biological fixation in both cemented and uncemented implants.
Extensor Mechanism Failure
Failure of the extensor mechanism can have a significant impact on patient function. In proximal tibial resections, the patellar tendon is sectioned 1-2 cm from its insertion on the tibial tubercle for oncologic margins [68 •• ] . Achieving the appropriate patellar height, tendon fixation and healing to the implant can be problematic. Synthetic materials, such as the Trevira tube (Implantcast, Germany) and artificial ligaments, were used independently in previous series; however, high rates of infection led to routine rotational gastrocnemius flaps for implant coverage [9, 51 •• , 72, 83, 84 • ]. This was first described by Dubousset et al. [72] and involves detaching and transposing the medial head of the gastrocnemius muscle (plus or minus the hemi-soleus) to cover the implant. The patellar tendon and joint capsule are then repaired to the leading edge of the muscle with non-absorbable sutures followed by skin grafting if necessary. The patients' flexion is limited in the initial postoperative period so as to optimise healing and [32 • ] reported a mean extensor lag of 17.9°i n 52 patients with a proximal tibial EPR; however, passive ROM was full and the authors surmised that recurvatum was prevented by the extensor stop mechanism on the femoral side of the prosthesis. MSTS scores were 82 % despite the lack of extensor power. In our centre, patients are allowed to bear weight immediately postoperatively, but are limited to 60°of flexion for 6 weeks.
The Rizzoli Institute reported a 3 % incidence of extensor mechanism rupture in a large series of 225 patients. Mean extensor lag was 12°; however, the type of extensor mechanism repair, how it was attached to the implant and any augmentation were not found to be associated with MSTS score [68 •• ]. Jentzsch et al. [86 • ] found that a significant number of patients developed patella alta within 2 years of index surgery in a small series of 14 patients; this was associated with extensor lag (mean, 17°) and reduced MSTS scores. Although more common in the proximal tibia, complications involving the extensor mechanism can equally affect patients with distal femoral sarcomas. Schwab et al. [87] found that 63 % of patients undergoing distal femoral reconstruction after sarcoma resection had patellar complications, ranging from impingement and patella baja to osteonecrosis and fracture. Impingement and patella baja were associated with worse ISOLS scores. One study reported an increase in isokinetic muscle strength compared to the contralateral limb in patients with a distal femoral resection with patellar resurfacing relative to those without [88] . However, overwhelming evidence for patellar resurfacing at index surgery is lacking and is not routinely performed in our institution.
Functional Outcomes in the Knee
Oncologic outcomes have proven to be similar in ablative and limb-salvage procedures, and as such, the focus of research has shifted to optimising patient function and quality of life. The young patient population treated for sarcoma is of particular interest as they are living longer, placing increased demands on their implants, and have higher expectations of their reconstructions. Gait analysis has gained in popularity, and in 2013, Okita et al. [89 • ] compared eight patients with endoprostheses about the knee with eight matched healthy subjects. They demonstrated increased negative joint forces and compensation in the ipsilateral ankle, contralateral knee and bilateral hips during gait analysis. Jentzsch et al. [86 • ] found that patella alta after proximal tibia resection, as measured by the Blackburn-Peel Index, was associated with inferior functional outcome. Functional outcome scores have ranged from a mean MSTS of 61-90 % across a number of large series [9] [10] [11] 16 ] reported the functional outcomes of 27 patients with a growing prosthesis about the knee; emotional acceptance and paediatric outcomes data collection instrument (POD-CI) happiness domains were high and were not significantly associated with complications. The physical function domains of the MSTS and PODCI were the lowest scores for any domain, but were not different across implant manufacturer or based on the tumour location. Quality of life indicators are under development, but early findings have not shown a significant difference amongst different endoprosthetic reconstruction techniques.
Conclusions
Endoprosthetic reconstruction after resection of distal femoral and proximal tibial primary bone malignancies is an oncologically safe method of preserving the limb and optimising patient function and quality of life. Innovation in implant design has led to a significant reduction in implant-related complications, and a variety of prosthetic options show similar results. However, implant revision rates remain high over long-term follow-up for a host of reasons. As such, anticipated outcomes and expectations of function and quality of life following tumour resection should be discussed in detail with patients and their families prior to embarking on any reconstructive surgery.
